glp 1 drugs and blood clots A recent study suggests that GLP-1 medications, commonly prescribed for managing diabetes obesity, may also lower the risk of dangerous clots., The study’s lead author, Dr. Rushad Patell of April 2025 PEP Talk: Weight,
Description
It estimated that in 2022 there were 2.5 billion adults (18 years and older) who were overweight, including more than 890 million who were obese
Increasing gradually gives your body time to adapt and helps you find the most effective dose for ongoing weight loss
Common GLP-1 medications include: Liraglutide : Marketed as Saxenda and Victoza
This study aimed to summarize these indicators through a meta-analysis
The popularity of these drugs has led to a sea of GLP-1 offerings flooding the marketnot all of them FDA-approved
While improved glucose metabolism and weight loss matter, a large portion of the benefit appears to stem from direct or indirect anti-inflammatory effects that are independent of those metabolic changes
